Friday's pre-open news flow is led by a pair of capital raises with clear strategic purpose: MedPal AI (AIM:MPAL) is deploying £5m to build out a care-home medication platform and position itself ahead of the UK's oral Wegovy launch, while Helix Exploration (AIM:HEX) is using a £17.6m raise to acquire a US helium liquefaction facility at a steep discount to replacement cost. Elsewhere, Craneware issued a profit warning and Ilika closed a fundraise to advance its solid-state battery programmes.
MedPal AI raises £5m for care-home platform and oral Wegovy clinic
MedPal AI (AIM:MPAL), the AIM-traded digital pharmacy group, has raised £5m to fund two concurrent strategic moves: completing a closed-loop medication management platform for care homes, and launching a dedicated clinic for oral Wegovy ahead of the drug's UK availability on 6 July. The dual focus positions the company at the intersection of two high-growth healthcare verticals, institutional medication automation and the rapidly expanding GLP-1 weight-loss market.
The care-home software acquisition is intended to create an end-to-end digital prescribing and dispensing loop within residential care settings, a segment where medication errors and administrative friction remain persistent problems. The oral Wegovy clinic launch is timed to coincide with what MedPal expects to be significant consumer demand following the UK commercial rollout of the oral formulation.
Helix Exploration acquires US helium liquefaction plant at deep discount
Helix Exploration (AIM:HEX) is acquiring the Keyes Helium Complex in Oklahoma, backed by a £17.6m equity raise. The facility is one of only six operational helium liquefaction plants in the United States, giving Helix direct access to a critical and scarce piece of downstream infrastructure. The company claims the acquisition price represents a 65% discount to replacement cost, a valuation gap it attributes to the complexity of sourcing and permitting such assets in the current environment.
The deal marks a significant step change for the AIM-listed producer, which has until now focused on upstream helium development. Ownership of a liquefaction facility provides the ability to process and sell liquid helium, the form required by most industrial and scientific end-users, rather than remaining dependent on third-party processing capacity.
Harbour Energy places existing shares in £112m accelerated bookbuild
Harbour Energy (HBR) has completed an accelerated placing of £112m worth of shares. Notably, the placing involved existing shares held by a third-party seller rather than the issuance of new equity, meaning no proceeds flow to Harbour itself. The transaction does not dilute existing shareholders but does bring a significant block of stock to market in a single accelerated process.
Craneware warns FY26 revenue and profit will miss forecasts
Craneware (AIM:CRW), the Edinburgh-based healthcare software group focused on the US hospital market, has issued a profit warning, telling investors that both revenue and profit for the financial year ending June 2026 will fall short of market expectations. Chief executive Keith Neilson acknowledged the shortfall directly, saying the company was "naturally disappointed not to have delivered the growth that we expected in FY26," while maintaining that "the long-term opportunity remains intact."
The warning will weigh on sentiment toward the stock given Craneware's historically premium rating, which has been underpinned by consistent recurring revenue growth from its Trisus platform. No specific figures were provided in the announcement, leaving analysts to revise their models ahead of full-year results.
Ilika closes fundraise to advance Stereax and Goliath battery programmes
Ilika (AIM:IKA) has closed a capital raise to fund continued development across its two solid-state battery platforms. The Stereax programme, targeting miniaturised batteries for active implantable medical devices, and the Goliath platform, aimed at electric vehicle applications, will both benefit from the proceeds. Chief executive Graeme Purdy highlighted that Goliath has reached what he described as "an exciting intersection point with the urgent sovereign needs of the defence sector," signalling that military applications are now a live commercial avenue alongside the EV roadmap.
